Strategy + transformation
We take a collaborative and insight-led approach to shaping strategy and enabling transformation – grounded in policy, market, and system realities specific to the life sciences sector. Our approach includes:
- Opportunity definition and challenge framing to clarify objectives, success criteria, and decision points across market entry, access, or transformation initiatives.
- Insight gathering through stakeholder consultation, policy review, data analysis, and competitive scanning to inform context, risks, and opportunities.
- Co-design and strategic refinement with internal teams and external stakeholders to stress-test assumptions, align priorities, and shape actionable strategy.
- Development of strategic roadmaps and implementation plans to support execution with clear milestones, enablers, risks, and governance structures.
- Alignment with system context and strategic priorities to ensure feasibility, relevance, and long-term impact within the Australian healthcare environment.
This structured yet flexible approach ensures our strategies are tailored, practical, stakeholder-aligned, and system-aware.
Our work combines commercial acumen, policy insight, and deep knowledge of the Australian healthcare environment to deliver strategies that are both ambitious and grounded in reality. What this looks like:
- Launch readiness to align internal functions, messaging, and market activities ahead of product introduction.
- Go-to-market planning that defines access pathways, stakeholder engagement, and value positioning.
- Market entry and expansion strategies tailored to public and private system dynamics.
- Private market feasibility assessments to evaluate access potential, pricing models, and commercial viability.
- Competitive and landscape assessments to identify gaps, threats, and opportunities in the current environment.
Reports:
Fighting Superbugs: Ensuring Australia is ready to combat the rise of drug resistant infections
Evohealth Report Fighting Superbugs: Ensuring Australia is ready to…
Cell and gene therapies: Rising to the challenge Scorecard 2023
Scorecard 2023 Measuring Australia’s progress towards timely and…
Time to Act: protecting our children from RSV
Evohealth Report Time to Act: protecting our children from RSVRespiratory..
Preparing Australia: Designing an Australian Centre for Disease Control (CDC)
For many Australians, the COVID-19 pandemic has been their defining…
Cell and gene therapies: Rising to the challenge Scorecard 2023
Evohealth White Paper The burden of cancer in AustraliaIn Australia,…
ASCVD in Taiwan: A public health priority
Evohealth White Paper ASCVD in Taiwan: A public health…
Cell and gene therapies: Rising to the challenge
Evohealth White Paper Cell and gene therapies: Rising to the…
Australia’s Cholesterol Heartache
A simple roadmap for urgent action on cholesterol managementAustralia has…